(Q33698015)

English

Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia: long-term follow-up of a phase 2 study

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia: long-term follow-up of a phase 2 study (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

Hagop Kantarjian

10

object named as

Hagop Kantarjian

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

5

object named as

Stefan Faderl

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jorge Eduardo Cortes

4

object named as

Jorge Cortes

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

2

object named as

Farhad Ravandi

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

9

object named as

Sherry Pierce

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Guillermo Garcia-Manero

6

object named as

Guillermo Garcia-Manero

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

3

object named as

Elihu Estey

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Michael E Rytting

1

object named as

Michael Rytting

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

7

object named as

Sima Jeha

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Souzanne Ouzounian

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

0 references

publication date

1 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

116

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

5272-5278

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434864

21 June 2018

Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434864

21 June 2018

Anthracycline dose intensification in acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434864

21 June 2018

High-dose cytosine arabinoside in the treatment of acute myeloid leukemia: Review of three randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434864

21 June 2018

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434864

21 June 2018

Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434864

21 June 2018

Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434864

21 June 2018

Timed sequential therapy of human leukemia based upon the response of leukemic cells to humoral growth factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434864

21 June 2018

Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25516

21 January 2018

Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25516

21 January 2018

Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25516

21 January 2018

Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25516

21 January 2018

Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25516

21 January 2018

Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25516

21 January 2018

In vivo cell growth and pharmacologic determinants of clinical response in acute myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20665501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20665501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20665501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A two-step timed sequential treatment for acute myelocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20665501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/20665501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20665501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.25516

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33698015&oldid=1968143116"